Linus Health

Linus Health

Digital platform for cognitive assessments

About Linus Health

Simplify's Rating
Why Linus Health is rated
B+
Rated B on Competitive Edge
Rated A on Growth Potential
Rated B on Rating Differentiation

Industries

AI & Machine Learning

Biotechnology

Healthcare

Company Size

51-200

Company Stage

Series B

Total Funding

$64.9M

Headquarters

Waltham, Massachusetts

Founded

2019

Overview

Linus Health provides tools for the early detection of Alzheimer's and other forms of dementia by enhancing cognitive assessments with artificial intelligence. Their main product is a digital cognitive assessment platform that combines traditional tests with AI-driven analysis, allowing for efficient and scientifically validated early detection. A key feature is DCTclock, an AI-enhanced version of the traditional clock drawing test, developed through research at MIT and Lahey. The company's goal is to improve patient outcomes by enabling timely and accurate cognitive assessments in a growing market for dementia care.

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing dementia cases worldwide increase demand for Linus Health's cognitive care solutions.
  • Remote assessments improve early detection rates and streamline patient care.
  • Acquisition of Together Senior Health enhances Linus Health's platform for cognitive decline intervention.

What critics are saying

  • Rapid AI development may lead to increased competition from new entrants.
  • Integration risks exist with the acquisition of Together Senior Health.
  • Reliance on FDA approval could delay product launches and revenue growth.

What makes Linus Health unique

  • Linus Health uses AI to enhance cognitive assessments for early dementia detection.
  • Their DCTclock is an AI-enhanced upgrade to the traditional clock drawing test.
  • The platform offers iPad-based assessments with automated scoring and multi-language support.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$64.9M

Above

Industry Average

Funded Over

2 Rounds

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Above Average

Industry standards

$35M
$45M
Linktree
$55M
Linus Health
$65M
Substack
$100M
ClickUp

Benefits

Health, dental, vision & life insurance

Unlimited PTO

Parental leave

401K with 6% match

Performance Bonus

Employee Stock Purchase Plan

Work From Home Policy

Employee Referral Incentive program

Company Social Outings

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 4%

2 year growth

↑ 6%
Hit Consultant
Mar 21st, 2025
Linus Health Launches AI-Powered Remote Assessment to Combat Undetected Cognitive Impairment

- Linus Health has introduced Anywhere for Health Systems(TM), an innovative, FDA-listed, AI-enhanced cognitive assessment designed to address the critical issue of undetected mild cognitive impairment (MCI), a precursor to dementia.

Hit Consultant
Mar 21st, 2025
Linus Health Launches Ai-Powered Remote Assessment To Combat Undetected Cognitive Impairment

Linus Health Launches AI-Powered Remote Assessment to Combat Undetected Cognitive Impairment. by Jasmine Pennic 03/21/2025 Leave a Comment. What You Should Know: â€“ Linus Health has introduced Anywhere for Health Systems™, an innovative, FDA-listed, AI-enhanced cognitive assessment designed to address the critical issue of undetected mild cognitive impairment (MCI), a precursor to dementia. â€“ The new solution empowers health systems to conduct accurate and efficient cognitive evaluations remotely, significantly improving early detection rates and streamlining patient care.Delivering Clinical-Grade Cognitive Assessments RemotelyThe alarming statistic that 92% of MCI cases go undetected highlights a major gap in current healthcare practices. Traditional MCI detection methods, involving in-person screenings and lengthy neuropsychological evaluations, are often time-consuming and resource-intensive, placing a strain on already overburdened clinicians.Anywhere for Health Systems™ offers a solution by providing a convenient and rapid assessment that patients or their care partners can administer from home via laptop, tablet, or phone, at the request of their primary care provider (PCP). This FDA Class II medical device utilizes a peer-reviewed battery of tests to assess four critical cognitive domains.Anywhere for Health Systems™ complements Linus Health’s broader suite of cognitive health solutions, including Radar and a portfolio of digital cognitive assessments and personalized action plans. Linus Health collaborates with health systems to tailor workflows and optimize patient and provider experiences.“This self-administered test is the solution healthcare systems have been looking for,” said John Showalter, MD, MSIS, chief strategy and product officer at Linus Health

Business Wire
Jan 14th, 2025
Neurogen Biomarking Announces Collaboration with Linus Health Bringing Easy Access to Cutting-Edge Technology to Support Early Detection of Mild Cognitive Impairment and Dementia due to Alzheimer's Disease

Neurogen Biomarking announces collaboration with Linus Health bringing easy access to cutting-edge technology to support early detection of Mild Cognitive Impairment and dementia due to Alzheimer's disease.

Healthcare Business Outlook
Nov 7th, 2024
Enabling the Field of Cognitive Care to be Less Cumbersome

Brook Health, a leader in remote patient care and AI-powered health support, has officially announced a partnership with Linus Health, a digital health company enabling early detection of Alzheimer's and other dementias, to conceive a simplistic brand of cognitive care.

Hit Consultant
Oct 16th, 2024
Hlth 2024: 21 Executives Share Their Predictions And Insights

As HLTH 2024 prepares to convene in Las Vegas, the anticipation for groundbreaking insights and transformative discussions is palpable. To get a glimpse into the key themes and predictions shaping this year’s event, we reached out to 21 digital health executives for their expert perspectives.From the rise of generative AI and the evolving role of virtual care to the increasing focus on health equity and value-based care, these industry leaders offer a diverse range of perspectives on the most pressing challenges and promising opportunities facing the healthcare ecosystem.Join us as we delve into their predictions and explore the trends that are poised to redefine the future of healthcare at HLTH 2024.Ryne Natzke, chief revenue officer, TrustCommerce, a Sphere company, a provider of end-to-end integrated healthcare payments and security softwareAI, AI, and more AI! I’m looking forward to seeing how AI is being applied to help clinicians, patients, and other staff members provide better patient experiences and outcomes. Everything is moving so quickly that it will be exciting to get an update on where the industry is going.James Aita, director, Strategy and Business Development, Medicomp Systems, a physician-driven provider of diagnostically connected patient data solutionsOf course AI is the hot topic at HLTH this year–but with the new regulations from ASTP/ONC, the question is how can it be usable, trustworthy, transparent and helpful. I’m also interested in seeing who else is making AI and clinical data helpful at the point of care to reduce the burden on clinicians and inform patient care.Lyle Berkowitz, MD, CEO, KeyCare, the nation’s first Epic-based virtual care companyI always look forward to HLTH and seeing presentations of the newest cutting-edge technology and ideas. This year, I’m expecting deeper and wider use cases of AI to lead the charge. But in addition to technology innovations, I’m also hoping we will hear about other people and process topics such as how to set up virtual care teams and how to rethink primary care physician compensation to better align around adoption of automation and team-based care.Kazu Okuda, MD, CEO and co-founder of Universal Brain, whose platforms use brain-function measurement to drive precision psychiatryThe emergence of personalized treatment is an exciting field that I expect to take center stage at HLTH this year

Recently Posted Jobs

Sign up to get curated job recommendations

Director of Business Development - Life Sciences

Remote in USA

Senior Financial Analyst

$125k - $150k/yr

Remote in USA

Lead Analyst - FP&a

$125k - $150k/yr

Remote in USA

See All Jobs

Linus Health is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Linus Health's jobs every few hours, so check again soon! Browse all jobs →

People Also Viewed

Discover companies similar to Linus Health

Deliberate.ai

Deliberate.ai

New York City, New York

Novoic

Novoic

London, United Kingdom

Luma AI

Luma AI

San Francisco, California

Senior Financial Analyst

$125k - $150k/yr

Remote in USA

Lead Analyst - FP&a

$125k - $150k/yr

Remote in USA

See All Jobs

Linus Health is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Linus Health's jobs every few hours, so check again soon! Browse all jobs →

People Also Viewed

Discover companies similar to Linus Health

Deliberate.ai

Deliberate.ai

New York City, New York

Novoic

Novoic

London, United Kingdom

Luma AI

Luma AI

San Francisco, California